Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Cycclone Inc CDBT

Cycclone, Inc., formerly China Dasheng Biotechnology Co., is an engine, not motor, design and development company with a focus on permanent magnets as the drive force. The Company has a component development facility in Bangalow, New South Wales, Australia, which engages in specific component prototype creation and development along with assembly. It also has a production CNC Machine Shop in... see more

OTCPK:CDBT - Post Discussion

Cycclone Inc > $CDBT - Acquisition of Cycclone Magnetic Engines
View:
Post by CashSeeker on Jun 10, 2024 12:59pm

$CDBT - Acquisition of Cycclone Magnetic Engines

 
$CDBT Enters Agreement to Acquire Cycclone Magnetic Engines, Inc., the Founding Company of the Magnetic Engine Project
$CDBT Enters Agreement to Acquire Cycclone Magnetic Engines, Inc., the Founding Company of the Magnetic Engine Project
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities